Scholars Central

Conference abstractPublished 15 Mar 2017

Endothelial progenitor cells and apoptotic endothelial cell-derived microparticles as biomarker of heart failure phenotypes

Authors: Alexander E Berezin

Zaporozhye State Medical University, Ukraine

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Chronic heart failure (HF) remains a leading cause of cardiovascular (CV) mortality and morbidity worldwide. Aim: The aim of the study was to investigate whether the pattern of angiogenic endothelial progenitor cells (EPCs) and apoptotic endothelial cell-derived microparticles (EMPs) would be able to differentiate HF with reduced (HFrEF) and preserved (HFpEF) ejection fraction. Methods: 164 chronic HF subjects met inclusion criteria. Patients with global left ventricular ejection fraction âÂ?¥50% were categorized as the HFpEF group (n=79) and those with âÂ?¤45% as the HFrEF group (n=85). Therefore, to compare the circulating levels of biological markers, 35 control subjects without HF were included in the study. All control individuals were age- and sex-matched chronic HF patients. The serum level of biomarkers was measured at baseline. The flow cytometric technique was used for predictably distinguishing circulating cell subsets depending on expression of CD45, CD34, CD14, Tie-2, and CD309 antigens and determining endothelial cell-derived micro particles. CD31+/annexin V+ was defined as apoptotic endothelial cell-derived MPs, MPs labeled for CD105+ or CD62E+ were determined as MPs produced due to activation of endothelial cells. Results: In multivariate logistic regression model T2DM (R2=0.26; P=0.001), obesity (R2=0.22; P=0.001), previous MI (R2=0.17; P=0.012), galectin-3 (R2=0.67; P=0.012), CD31+/annexin V+ EMPs (R2=0.11; P=0.001), NT-proBNP (R2=0.11; P=0.046), CD14+CD309+ cells (R2=0.058; P=0.001), and CD14+СD309+ Tie-2+ cells (R2=0.044; P=0.028) were found as independent predictors of HFpEF. Using multivariate Cox-regression analysis adjusted etiology (previous myocardial infarction), cardiovascular risk factors (obesity, type 2 diabetes mellitus), we found that NT-proBNP (OR 1.08; 95% CI=1.03âÂ?Â?1.12; P=0.001) and CD31+/annexin V+EMPs to CD14+CD309+ cells ratio (OR 1.06; 95% CI=1.02âÂ?Â?1.11; P=0.02) were independent predictors for HFpEF. Conclusion: We found that CD31+/annexin V+EMPs to CD14+CD309+ cells ratio added to NT-proBNP, clinical data and cardiovascular risk factors has exhibited the best discriminate value and higher reliability to predict HFpEF compared with NTproBNP and clinical data/cardiovascular risk factors alone.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Alexander E Berezin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels